journal article·2025-10Open access

Advances in the rational design of ionizable lipids for mRNA therapeutics

Yeji Lee, Kaiyuan Guo, Miyoung Oh, Eunbin Kim, Yujeong Jeong, Youngyoon Yoon, Yelim Choi, Yuna Hwang, Yongjoo Byeon, Yizhou Dong, Hyukjin Lee

Materials Today· Volume 89

Abstract

Ionizable lipids are key components in lipid nanoparticles (LNPs) for nucleic acid therapeutics, primarily facilitating endosomal escape. Beyond this function, recent advances have demonstrated their broader roles, including immunogenicity modulation, toxicity reduction, and tissue-specific targeting. This review categorizes current approaches in ionizable lipid design, including functionalized lipid modifications, high-throughput combinatorial libraries, and machine learning-driven discovery methods. We explore how these strategies expand the chemical diversity of ionizable lipids, enabling the identification of novel structures with enhanced delivery properties and specialized biological functions. By integrating computational and experimental methodologies, this review provides a comprehensive framework for guiding the next generation of ionizable lipids in nanoparticle-based drug delivery systems.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · RNA and protein synthesis mechanisms · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (98)

Show source-provided references
1. Lipid Nanoparticle Systems for Enabling Gene Therapies10.1016/j.ymthe.2017.03.013 ↗
2. Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling10.1038/nbt.2614 ↗
3. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo10.1002/anie.201203263 ↗
4. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines10.1038/s41565-023-01404-4 ↗
5. Imidazole-based Synthetic Lipidoids for In Vivo mRNA delivery into Primary T Lymphocytes10.1002/anie.202008082 ↗
6. Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA10.1038/s41551-023-01082-6 ↗
7. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing10.1038/s41587-023-01679-x ↗
8. Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery10.1038/s41467-024-55072-6 ↗
9. Review of machine learning for lipid nanoparticle formulation and process development10.1016/j.xphs.2024.09.015 ↗
10. Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid-Nanoparticle Components for Therapeutic and Vaccine applications
11. An ionizable lipid toolbox for RNA delivery10.1038/s41467-021-27493-0 ↗
12. The Endosomal Escape of Nanoparticles: Toward more Efficient Cellular delivery10.1021/acs.bioconjchem.8b00732 ↗
13. Next-Generation Lipids in RNA Interference Therapeutics10.1021/acsnano.7b04734 ↗
14. Lipid nanoparticles for mRNA delivery10.1038/s41578-021-00358-0 ↗
15. The Importance of Apparent pKa in the Development of Nanoparticles Encapsulating siRNA and mRNA10.1016/j.tips.2021.03.002 ↗
16. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs10.1038/s41565-019-0591-y ↗
17. Pharmacokinetics of Patisiran, the first Approved RNA Interference Therapy in patients with Hereditary Transthyretin-Mediated Amyloidosis10.1002/jcph.1553 ↗
18. The role of lipid components in lipid nanoparticles for vaccines and gene therapy10.1016/j.addr.2022.114416 ↗
19. A Novel Amino Lipid Series for mRNA delivery: improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates10.1016/j.ymthe.2018.03.010 ↗
20. Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid delivery10.1007/s11095-022-03460-2 ↗
21. Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation10.1038/s41467-024-50093-7 ↗
22. Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability10.1038/s41541-023-00751-6 ↗
23. Ansell SM, Du, X. , inventorLipids and lipid nanoparticle formulations for delivery of nucleic acids. 2019.
24. A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing10.1016/j.celrep.2018.02.014 ↗
25. CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis10.1056/NEJMoa2107454 ↗
26. Phase 1 Two-Part (Open-label, Single Ascending Dose (Part 1) and Open-label, Single Dose Expansion (Part 2)) Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM) [Internet]. 2020. Available from: https://clinicaltrials.gov/study/NCT04601051.
27. Lessons from the first-in-human in vivo CRISPR/Cas9 editing of the TTR gene by NTLA-2001 trial in patients with transthyretin amyloidosis with cardiomyopathy
28. Phase 1/2 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2002 in Adults With Hereditary Angioedema (HAE) [Internet]. 2021. Available from: https://clinicaltrials.gov/study/NCT05120830.
29. Morrissey DVea, inventorLipid Nanoparticle Formulations for Crispr/cas Components2019.
30. SMART-lipid nanoparticles enabled mRNA vaccine elicits cross-reactive humoral responses against the omicron sub-variants10.1016/j.ymthe.2024.02.028 ↗
31. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation10.1038/s41587-019-0247-3 ↗
32. An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell responses10.1021/acsnano.3c02251 ↗
33. Novel less toxic, Lymphoid Tissue-Targeted Lipid Nanoparticles Containing a Vitamin B5-Derived Ionizable Lipid for mRNA Vaccine delivery
34. Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer10.1007/s12274-019-2308-9 ↗
35. Nanomaterials-Mediated Co-Stimulation of Toll-like Receptors and CD40 for Antitumor Immunity10.1002/adma.202207486 ↗
36. Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles10.1038/s41467-024-48461-4 ↗
37. Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection10.1126/sciadv.abb4429 ↗
38. Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system10.1038/s41563-024-02114-5 ↗
39. Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics10.1038/s41467-025-57488-0 ↗
40. Piperazine‐Derived Bisphosphonate‐Based Ionizable Lipid Nanoparticles Enhance mRNA delivery to the Bone Microenvironment10.1002/anie.202415389 ↗
41. Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery10.1038/s41551-023-01030-4 ↗
42. In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors10.1038/s41467-024-45537-z ↗
43. Engineered lipid nanoparticles enable therapeutic gene silencing of GTSE1 for the treatment of liver fibrosis10.1016/j.jconrel.2024.08.012 ↗
44. Aung H, Sivakumar A, Gholami S, Venkateswaran S, Gorain B. An overview of the anatomy and physiology of the lung. Nanotechnology-based targeted drug delivery systems for lung cancer. 2019:1-20.10.1016/B978-0-12-815720-6.00001-0 ↗
45. Mechanisms of lung fibrosis resolution10.1016/j.ajpath.2016.01.018 ↗
46. High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models10.1038/s41467-024-45422-9 ↗
47. Combinatorial development of nebulized mRNA delivery formulations for the lungs10.1038/s41565-023-01548-3 ↗
48. Tumor-Tailored Ionizable Lipid Nanoparticles Facilitate IL-12 Circular RNA delivery for Enhanced Lung Cancer Immunotherapy
49. COVID-19 vaccination: intramuscular injection technique10.12968/bjon.2021.30.6.350 ↗
50. Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects10.1073/pnas.2309472120 ↗
51. Rational design and modular synthesis of biodegradable ionizable lipids via the Passerini reaction for mRNA delivery10.1073/pnas.2409572122 ↗
52. Subcutaneous Injection volume of Biopharmaceuticals-pushing the Boundaries10.1016/j.xphs.2016.05.029 ↗
53. Performing subcutaneous injections: a literature review10.1111/j.1741-6787.2005.00030.x ↗
54. Subcutaneous vaccine administration - an outmoded practice10.1080/21645515.2020.1814094 ↗
55. Strategies for intranasal delivery of vaccines10.1007/s13346-012-0085-z ↗
56. COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges10.1080/21645515.2022.2045853 ↗
57. Applying machine learning to identify ionizable lipids for nanoparticle-mediated delivery of mRNA
58. Representations of lipid nanoparticles using large language models for transfection efficiency prediction10.1093/bioinformatics/btae342 ↗
59. Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy
60. Structure–activity relationships of pH-responsive and ionizable lipids for gene delivery10.1016/j.ijpharm.2022.121596 ↗
61. High-throughput synthesis and optimization of ionizable lipids through A3 coupling for efficient mRNA delivery10.1186/s12951-024-02919-1 ↗
62. High-throughput screening of nanoparticles in drug delivery10.1063/5.0057204 ↗
63. Lipid nanoparticles for drug delivery10.1002/anbr.202100109 ↗
64. Merging data curation and machine learning to improve nanomedicines10.1016/j.addr.2022.114172 ↗
65. Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery
66. PaDEL‐descriptor: an open source software to calculate molecular descriptors and fingerprints10.1002/jcc.21707 ↗
67. Todeschini R, Consonni V. Handbook of molecular descriptors: John Wiley & Sons; 2008.10.1007/978-1-4020-9783-6_3 ↗
68. Virtual computational chemistry laboratory–design and description10.1007/s10822-005-8694-y ↗
69. Extended-connectivity fingerprints10.1021/ci100050t ↗
70. Neuraldecipher–reverse-engineering extended-connectivity fingerprints (ECFPs) to their molecular structures10.1039/D0SC03115A ↗
71. A probabilistic molecular fingerprint for big data settings10.1186/s13321-018-0321-8 ↗
72. O'Boyle N, Dalke A. DeepSMILES: an adaptation of SMILES for use in machine-learning of chemical structures. 2018.10.26434/chemrxiv.7097960.v1 ↗
73. Machine learning prediction of empirical polarity using SMILES encoding of organic solvents10.1007/s11030-022-10559-6 ↗
74. Convolutional networks on graphs for learning molecular fingerprints
75. Gilmer J, Schoenholz SS, Riley PF, Vinyals O, Dahl GE, editors. Neural message passing for quantum chemistry. International conference on machine learning; 2017: PMLR.
76. A comprehensive survey on graph neural networks10.1109/TNNLS.2020.2978386 ↗
77. Graph neural networks10.1038/s43586-024-00294-7 ↗
78. Graph neural networks: a review of methods and applications10.1016/j.aiopen.2021.01.001 ↗
79. Deep learning for deep chemistry: optimizing the prediction of chemical patterns10.3389/fchem.2019.00809 ↗
80. Machine learning toxicity prediction: latest advances by toxicity end point10.1021/acsomega.2c05693 ↗
81. Raschka S. Model evaluation, model selection, and algorithm selection in machine learning. arXiv preprint arXiv:181112808. 2018.
82. Chen T, Guestrin C, editors. Xgboost: A scalable tree boosting system. Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining; 2016.10.1145/2939672.2939785 ↗
83. Random forests10.1023/A:1010933404324 ↗
84. Applications of support vector machine (SVM) learning in cancer genomics
85. Using random forest to model the domain applicability of another random forest model10.1021/ci400482e ↗
86. Machine learning and deep learning10.1007/s12525-021-00475-2 ↗
87. Machine learning and deep learning applications-a vision10.1016/j.gltp.2021.01.004 ↗
88. Analyzing learned molecular representations for property prediction10.1021/acs.jcim.9b00237 ↗
89. Pushing the boundaries of molecular representation for drug discovery with the graph attention mechanism10.1021/acs.jmedchem.9b00959 ↗
90. Molecular transformer: a model for uncertainty-calibrated chemical reaction prediction10.1021/acscentsci.9b00576 ↗
91. From machine learning to deep learning: progress in machine intelligence for rational drug discovery10.1016/j.drudis.2017.08.010 ↗
92. Campesato O. Artificial intelligence, machine learning, and deep learning: Mercury Learning and Information; 2020.10.1515/9781683924654 ↗
93. Representations of lipid nanoparticles using large language models for transfection efficiency prediction10.1093/bioinformatics/btae342 ↗
94. Deep-learning-based drug–target interaction prediction10.1021/acs.jproteome.6b00618 ↗
95. Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry10.1038/s41563-024-01867-3 ↗
96. AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery10.1038/s41467-024-50619-z ↗
97. Rational Design of Lipid Nanoparticles for Enhanced mRNA Vaccine delivery via Machine Learning
98. Surface engineering of lipid nanoparticles: targeted nucleic acid delivery and beyond10.52601/bpr.2023.230022 ↗